Abstract
A non-physiological amino acid, related to lysine, which can be synthesized as a white crystalline material freely soluble in water and of molecular weight 131 (Okamoto and Hijikata, 1975).
Acikaprin®, Afibrin®, Amicar®, Capracid®, Capramol®, Caprocid®, Caprolest®, Caprolisin®, EACA-Roche®, Eacina®, Ecapron®, Epsikapron®, Epsilon-Tachostyptan®, Hemocaprol®.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abiko Y., Iwamoto M. and Tomikawa M. (1969) Plasminogen-plasmin system V. A stoichiometric equilibrium complex of plasminogen and a synthetic inhibitor. Biochim. biophys. Acta (Amst.) 185, 424.
Ablondi F.B., Hagan J.J., Philips M. and DE Renzo E.C. (1959) Inhibition of plasmin, trypsin and streptokinase activated fibrinolytic system by epsilon-aminocaproic acid. Arch. Biochem. 82, 153.
Alkjaersig N., Fletcher A. P. and Sherry S. (1959) E-Aminocaproic acid: an inhibitor of plasminogen activation. J. biol. Chem. 234, 832.
Ambrus CM., Ambrus J.L., Lassman H.B. and Mink I.B. (1968) Studies on the mechanism of action of inhibitors of the fibrinolysin system. Ann. N. Y. Acad. Sci. 146, 430.
Andersson L., Nilsson I.M., Colleen S., Granstand B. and Melander B. (1968) Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA. Ann. N. Y. Acad. Sci. 146, 642.
Andersson L. (1972) Antifibrinolytic drugs in the treatment of urinary tract haemorrhage. Progr. Surg. (Basel) 10, 76.
Back N. and Steger R. (1968) Effect of inhibitors on kinin-releasing activity of proteases. Fed. Proc. 27, 96.
Beck E., Schmutzler R. and Duckert F. (1963) Inhibition of fibrinolysis and fîbrinogenolysis in man: comparison of E-aminocaproic acid and kallikrein inhibitor. Thrombos. Diathes. haemorrh. (Stuttg.) 10, 106.
Becker J. and Borgström S. (1968) Incidence of thrombosis associated with epsilonaminocaproic acid administration and with combined epsilon-aminocaproic acid and subcutaneous heparin therapy. Acta chir. scand. 134, 343.
Bennett B. and Ogston D. (1973) Natural and drug-induced inhibition of fibrinolysis. Clinics in Haematology 2, 135.
Brockway W.J. and Castellino F.J. (1972) Measurement of the binding of antifibrinolytic amino acids to various plasminogens. Arch. Biochem. 151, 194.
Frank M.M., Sergent J.S., Kane M. A. and Alling D.W. (1972) Epsilon aminocaproic acid therapy of hereditary angioneurotic edema. New Engl. J. Med. 286, 808.
Gordon A.M., Mcnicol G.P., Dubber A.H.C., Mcdonald G.A. and Douglas A.S. (1965) Clinical trial of epsilon-aminocaproic acid in severe haemophilia. Brit. med. J. i, 1632.
Gordon-Smith I. C., Hickman J. A. and Masri S. H. (1972) The effect of the fibrinolytic inhibitor epsilon-aminocaproic acid on the incidence of deep-vein thrombosis after prostatectomy. Brit.J. Surg. 59, 522.
Immergut M.A. and Stevenson T. (1965) The use of epsilon aminocaproic acid in the control of haematuria associated with haemoglobinopathies. J. Urol. (Baltimore) 93, 110.
Johnson A. L., Skoza L. and Claus E. (1962) Observations on epsilon aminocaproic acid. Thrombos. Diathes. haemorrh. (Stuttg.) 7, 203.
Kasonde J.M. and Bonnar J. (1975a) Aminocaproic acid and menstrual loss in women using intrauterine devices. Brit. Med. J. iv, 17.
Kasonde J.M. and Bonnar J. (1975b) Effect of ethamsylate and aminocaproic acid on menstrual blood loss in women using intrauterine devices. Brit. Med. J. iv, 21.
Korsan-Bengsten K., Ysander L. and Blohme G. (1969) Extensive muscle necrosis after long-term treatment with aminocaproic acid (EACA) in a case of hereditary periodic oedema. Acta med. scand. 185, 341.
Lawrence A.C.K., Ward-Mcquaid J.N. and Holdom G.L. (1966) The effect of epsilon aminocaproic acid on the blood loss after retropubic prostatectomy. Brit. J. Urol. 38, 308.
Lippman W. and Wishnick M. (1965) Effects of the administration of epsilon aminocaproic acid on catecholamine and serotonin levels in the rat and dog. J. Pharmacol, exp. Ther. 150, 196.
Madsen P.O. and Strauch A.E. (1966) The effect of aminocaproic acid on bleeding following transurethral prostatectomy. J. Urol. (Baltimore) 96, 255.
Mcnicol G.P., Fletcher A.P., Alkjaersig N. and Sherry S. (1961) Use of epsilon aminocaproic acid a potent inhibitor of fibrinolytic activity in management of postoperative haematuria. J. Urol. (Baltimore) 86, 829.
Mcnicol G.P., Fletcher A.P., Alkjaersig N. and Sherry S. (1962) The absorption, distribution and excretion of epsilon-aminocaproic acid following oral or intravenous administration to man. J. Lab. clin. Med. 59, 15.
Nilsson I.M. (1975) Local fibrinolysis as a mechanism for haemorrhage. Thrombos. Diathes. haemorrh. (Stuttg.) 34, 623.
Nilsson I.M., Andersson L. and Bjorkman S.E. (1966) Epsilon-aminocaproic acid (EACA) as a therapeutic agent. Based on 5 years clinical experience. Acta med. scand., suppl. 448.
Nilsson L. and Rybo G. (1965) Treatment of menorrhagia with epsilon-aminocaproic acid. Acta obstet. gynec. scand. 44, 467.
Nilsson L. and Rybo G. (1971) Treatment of menorrhagia. Amer. J. Obstet. Gynec. 110, 713.
Nolan S.P., Dixon S.H.Jr., Behrendt D.M. and Morrow A.G. (1968) The effects of epsilon-aminocaproic acid on ventricular performance and total peripheral vascular resistance. Ann. Surg. 167, 547.
Okamoto S. and Hijikata A. (1975) Rational approach to proteinase inhibitors. Drug Design 6, 143.
Prentice C.R.M. (1975) Indications for antifibrinolytic therapy. Thrombos. Diathes. haemorrh. (Stuttg.) 34, 634.
Raab W. (1968) Influence of antifibrinolytic substances on allergic reactions. Experiments with E-aminocaproic acid and amino-methyl-cyclohexane-carbonic acid. Experientia (Basel) 24, 250.
Ratnoff O. (1969) Epsilon aminocaproic acid. A dangerous weapon. New Engl. J. Med. 280, 1124.
Sack E., Spaet T. H., Gentile R.L. and Hudson P.B. (1962) Reduction of postprostatectomy bleeding by epsilon-aminocaproic acid. New. Engl. J. Med. 266, 541.
Smart C.J., Turnbull A.R. and Jenkins J.D. (1974) The use of frusemide and epsilon-aminocaproic acid in transurethral prostatectomy. Brit. J. Urol. 46, 521.
Verstraete M., Vermylen J. and Tyberghein J. (1968) Double-blind evaluation of the haemostatic effect of adrenochrome monosemicarbazone, conjugated oestrogens and epsilon aminocaproic acid after adenotonsillectomy. Acta haemat. (Basel) 40, 154.
Vinnicombe J. and Shuttleworth K.E.D. (1966a) Aminocaproic acid in the control of haemorrhage after prostatectomy. Safety of aminocaproic acid. A controlled trial. Lancet i, 232.
Vinnicombe J. and Shuttleworth K.E.D. (1966b) Aminocaproic acid in the control of haemorrhage after prostatectomy. A controlled trial. Lancet i, 230.
Walsh P.N., Rizza C.R., Matthews J.M., Eipe J., Kernoff P.B.A., Coles M.D., Bloom A.L., Kaufman B.M., Beck P., Hanan C.M. and Biggs R. (1971) Epsilon-aminocaproic acid therapy for dental extractions in haemophilia and Christmas disease: a double-blind controlled trial. Brit. J. Haemal. 20, 463.
Walsh P.N., Rizza C.R., Evans B.E. and Aledort L.M. (1975) The therapeutic role of epsilon-aminocaproic acid (EACA) for dental extractions in haemophiliacs. Ann. N. Y. Acad. Sci. 290, 267.
Walther P.J., Hill R.L. and Mckee P.A. (1974) The importance of the preactivation peptide in the two-stage mechanism of human plasminogen activation. J. biol. Chem. 250, 5926.
Warren J.W. Jr. and Stanley K.E.Jr. (1969) New anti-hemorrhagic agent. Epsilon aminocaproic acid for control of hemorrhage after transurethral prostatic resection: a control study. J. Kansas med. Soc. 20, 173.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1977 Martinus Nijhoff, P.O.B. 442, The Hague, The Netherlands
About this chapter
Cite this chapter
Verstraete, M. (1977). Report on epsilon aminocaproic acid (EACA) (6-aminohexanoic acid). In: Haemostatic Drugs. Springer, Dordrecht. https://doi.org/10.1007/978-94-010-1106-8_27
Download citation
DOI: https://doi.org/10.1007/978-94-010-1106-8_27
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-247-2020-0
Online ISBN: 978-94-010-1106-8
eBook Packages: Springer Book Archive